Skip to main content

Apixaban prevails in study of 163,000 DOAC users

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Apixaban prevails in study of 163,000 DOAC users

User login

Username

Password

Reset your password

Type	Lead	score